Bleakley Financial Group LLC purchased a new stake in Cigna Group (NYSE:CI – Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 10,089 shares of the health services provider’s stock, valued at approximately $2,908,000.
Several other hedge funds have also recently modified their holdings of CI. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Cigna Group by 11.7% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 45,235 shares of the health services provider’s stock worth $13,039,000 after buying an additional 4,738 shares during the last quarter. Maj Invest Holding A S lifted its position in Cigna Group by 2.4% during the third quarter. Maj Invest Holding A S now owns 422,728 shares of the health services provider’s stock valued at $121,854,000 after acquiring an additional 10,042 shares during the last quarter. Providence Capital Advisors LLC boosted its stake in Cigna Group by 1,016.8% in the third quarter. Providence Capital Advisors LLC now owns 8,510 shares of the health services provider’s stock valued at $2,453,000 after acquiring an additional 7,748 shares in the last quarter. National Pension Service grew its holdings in Cigna Group by 3.2% in the third quarter. National Pension Service now owns 683,751 shares of the health services provider’s stock worth $197,091,000 after purchasing an additional 21,203 shares during the last quarter. Finally, SCS Capital Management LLC increased its position in shares of Cigna Group by 39.1% during the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after purchasing an additional 8,609 shares in the last quarter. Hedge funds and other institutional investors own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently weighed in on CI. JPMorgan Chase & Co. lowered their price objective on Cigna Group from $428.00 to $375.00 and set an “overweight” rating for the company in a research report on Tuesday, November 4th. Sanford C. Bernstein reissued a “market perform” rating and issued a $307.00 price target on shares of Cigna Group in a report on Tuesday, January 6th. Robert W. Baird dropped their price target on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. Mizuho set a $325.00 price objective on shares of Cigna Group in a research report on Friday, January 9th. Finally, Leerink Partners lifted their target price on shares of Cigna Group from $270.00 to $297.00 and gave the stock a “market perform” rating in a research note on Friday, February 6th. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $330.63.
Cigna Group Price Performance
Shares of NYSE:CI opened at $282.97 on Tuesday. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00. The company has a current ratio of 0.74, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The company has a market cap of $75.59 billion, a PE ratio of 12.76, a price-to-earnings-growth ratio of 0.97 and a beta of 0.27. The company’s 50 day moving average is $279.03 and its 200 day moving average is $284.37.
Cigna Group (NYSE:CI – Get Free Report) last released its quarterly earnings data on Thursday, February 5th. The health services provider reported $8.08 EPS for the quarter, beating the consensus estimate of $7.88 by $0.20. Cigna Group had a net margin of 2.17% and a return on equity of 19.46%. The business had revenue of $72.50 billion for the quarter, compared to the consensus estimate of $69.53 billion. During the same period in the prior year, the firm earned $6.64 EPS. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.250- EPS. On average, sell-side analysts forecast that Cigna Group will post 29.77 EPS for the current year.
Cigna Group Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, March 19th. Stockholders of record on Thursday, March 5th will be issued a $1.56 dividend. This is a boost from Cigna Group’s previous quarterly dividend of $1.51. The ex-dividend date of this dividend is Thursday, March 5th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s payout ratio is presently 27.23%.
About Cigna Group
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
Recommended Stories
- Five stocks we like better than Cigna Group
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
